BRPI0823502A2 - pó nutricional estável - Google Patents

pó nutricional estável

Info

Publication number
BRPI0823502A2
BRPI0823502A2 BRPI0823502A BRPI0823502A BRPI0823502A2 BR PI0823502 A2 BRPI0823502 A2 BR PI0823502A2 BR PI0823502 A BRPI0823502 A BR PI0823502A BR PI0823502 A BRPI0823502 A BR PI0823502A BR PI0823502 A2 BRPI0823502 A2 BR PI0823502A2
Authority
BR
Brazil
Prior art keywords
nutritional powder
stable nutritional
stable
powder
nutritional
Prior art date
Application number
BRPI0823502A
Other languages
English (en)
Inventor
L Clinger Christine
E Katz Gary
M Boff Jeffrey
Bergana Marti
W Johns Paul
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of BRPI0823502A2 publication Critical patent/BRPI0823502A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pediatric Medicine (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dairy Products (AREA)
  • General Preparation And Processing Of Foods (AREA)
BRPI0823502A 2007-12-20 2008-10-29 pó nutricional estável BRPI0823502A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1531207P 2007-12-20 2007-12-20
PCT/US2008/081534 WO2009085386A2 (en) 2007-12-20 2008-10-29 Stable nutritional powder

Publications (1)

Publication Number Publication Date
BRPI0823502A2 true BRPI0823502A2 (pt) 2018-03-20

Family

ID=40788960

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0823502A BRPI0823502A2 (pt) 2007-12-20 2008-10-29 pó nutricional estável

Country Status (26)

Country Link
US (1) US8361534B2 (pt)
EP (1) EP2227099B1 (pt)
JP (1) JP2011507517A (pt)
CN (1) CN101998835A (pt)
AR (1) AR069839A1 (pt)
AU (1) AU2008343687A1 (pt)
BR (1) BRPI0823502A2 (pt)
CA (1) CA2708272C (pt)
CL (1) CL2008003807A1 (pt)
CO (1) CO6280446A2 (pt)
CR (1) CR11509A (pt)
DK (1) DK2227099T3 (pt)
DO (1) DOP2010000174A (pt)
EC (1) ECSP10010261A (pt)
ES (1) ES2535144T3 (pt)
GT (1) GT201000174A (pt)
IL (1) IL206200A (pt)
MX (1) MX2010006891A (pt)
MY (1) MY150500A (pt)
NZ (1) NZ585574A (pt)
PA (1) PA8808801A1 (pt)
PE (1) PE20091454A1 (pt)
RU (1) RU2479219C2 (pt)
TW (1) TWI418308B (pt)
WO (1) WO2009085386A2 (pt)
ZA (1) ZA201004029B (pt)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8968721B2 (en) 2005-12-28 2015-03-03 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
US8097245B2 (en) 2005-12-28 2012-01-17 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
US8460726B2 (en) 2006-12-18 2013-06-11 Advanced Bionutrition Corporation Dry food product containing live probiotic
WO2010111565A2 (en) 2009-03-27 2010-09-30 Advanced Bionutrition Corporation Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
SG10201605794PA (en) 2009-04-29 2016-09-29 Amarin Pharmaceuticals Ie Ltd Stable Pharmaceutical Composition And Methods Of Using Same
NZ624963A (en) 2009-04-29 2016-07-29 Amarin Pharmaceuticals Ie Ltd Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
WO2010138522A2 (en) * 2009-05-26 2010-12-02 Advanced Bionutrition Corporation Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making
EP3318255B1 (en) 2009-06-15 2021-03-10 Amarin Pharmaceuticals Ireland Limited Compositions and methods for treating stroke in a subject on concomitant statin therapy
TW201112967A (en) * 2009-09-16 2011-04-16 Abbott Lab Dryblended nutritional powders
AU2010298222B2 (en) 2009-09-23 2017-01-05 Amarin Pharmaceuticals Ireland Limited Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same
US8834951B2 (en) 2010-01-28 2014-09-16 Advanced Bionutrition Corporation Dry glassy composition comprising a bioactive material
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
WO2012021783A2 (en) 2010-08-13 2012-02-16 Advanced Bionutrition Corporation Dry storage stabilizing composition for biological materials
US11712429B2 (en) 2010-11-29 2023-08-01 Amarin Pharmaceuticals Ireland Limited Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
NZ744990A (en) 2010-11-29 2019-10-25 Amarin Pharmaceuticals Ie Ltd Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
TWI561175B (en) * 2011-03-31 2016-12-11 Meiji Co Ltd Flowable nutrition composition containing l-arginine and method for producing the same
US20120269929A1 (en) * 2011-04-22 2012-10-25 Hugh Lippman Fortified Milk-Based Nutritional Compositions
US20140287111A1 (en) * 2011-08-16 2014-09-25 Abbott Laboratories Use of ultrasonic energy in the production of nutritional powders
DK2757898T3 (en) 2011-09-20 2016-01-11 Abbott Lab Powdered nutritional formulations with spray-dried plant protein
US11291643B2 (en) 2011-11-07 2022-04-05 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
WO2013070735A1 (en) 2011-11-07 2013-05-16 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
ES2891473T3 (es) 2012-01-06 2022-01-28 Amarin Pharmaceuticals Ie Ltd Composiciones y métodos para reducir los niveles de alta sensibilidad (hs-CRP) en un sujeto
NZ727849A (en) 2012-06-29 2018-06-29 Amarin Pharmaceuticals Ie Ltd Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
WO2014074552A2 (en) 2012-11-06 2014-05-15 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy
US20140187633A1 (en) 2012-12-31 2014-07-03 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
US9452151B2 (en) 2013-02-06 2016-09-27 Amarin Pharmaceuticals Ireland Limited Methods of reducing apolipoprotein C-III
US9624492B2 (en) 2013-02-13 2017-04-18 Amarin Pharmaceuticals Ireland Limited Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
US20140271841A1 (en) 2013-03-15 2014-09-18 Amarin Pharmaceuticals Ireland Limited Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin
US20140328970A1 (en) * 2013-05-03 2014-11-06 Mead Johnson Nutrition Company Nutritional Composition Comprising Whey and Hydrolyzed Casein and Uses Thereof
US10966968B2 (en) 2013-06-06 2021-04-06 Amarin Pharmaceuticals Ireland Limited Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof
US20150065572A1 (en) 2013-09-04 2015-03-05 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing prostate cancer
US9585859B2 (en) 2013-10-10 2017-03-07 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
US10639334B2 (en) * 2014-01-07 2020-05-05 Mead Johnson Nutrition Company Pediatric nutritional composition with milk peptides for healthy growth and development
US10561631B2 (en) 2014-06-11 2020-02-18 Amarin Pharmaceuticals Ireland Limited Methods of reducing RLP-C
WO2015195662A1 (en) 2014-06-16 2015-12-23 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense ldl or membrane polyunsaturated fatty acids
US20170202260A1 (en) * 2014-07-21 2017-07-20 Abbott Laboratories Nutritional powder with specific antioxidants
MX2017004582A (es) * 2014-10-08 2017-10-12 Abbott Lab Composiciones nutricionales que comprenden un componente oxidable y un extracto de plantas solubles en agua.
JP6889699B2 (ja) 2015-07-29 2021-06-18 アドバンスド バイオニュートリション コープ． 特定栄養用途のための安定乾燥プロバイオティクス組成物
US12558395B2 (en) 2015-07-29 2026-02-24 Advanced Bionutrition Corp. Stable dry probiotic compositions for special dietary uses
US10406130B2 (en) 2016-03-15 2019-09-10 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
TW201900160A (zh) 2017-05-19 2019-01-01 愛爾蘭商艾瑪琳製藥愛爾蘭有限公司 用於降低腎功能下降之個體中的三酸甘油酯之組合物及方法
WO2019090093A1 (en) * 2017-11-03 2019-05-09 Advanced Bionutrition Corp. Composition containing viable microorganisms and methods of making
US11058661B2 (en) 2018-03-02 2021-07-13 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L
LT3750536T (lt) 2018-09-24 2026-03-25 Amarin Pharmaceuticals Ireland Limited Širdies ir kraujagyslių sistemos reiškinių rizikos subjekto organizme sumažinimo būdai
BR112022009189A2 (pt) 2019-11-12 2022-07-26 Amarin Pharmaceuticals Ie Ltd Métodos para reduzir o risco de eventos cardiovasculares em um sujeito com fibrilação atrial e/ou palpitação atrial
AU2022263358A1 (en) 2021-04-21 2023-11-30 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of heart failure

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4830861A (en) * 1988-07-14 1989-05-16 Bristol-Myers Company Low manganese high protein rice flour
US5013569A (en) * 1990-05-21 1991-05-07 Century Laboratories, Inc. Infant formula
US5021245A (en) 1990-05-22 1991-06-04 Abbott Laboratories Infant formula containing a soy polysaccharide fiber source
US5405637A (en) * 1993-06-30 1995-04-11 Bristol-Myers Squibb Company Milk protein partial hydrolysate and infant formula containing same
US6136858A (en) 1994-01-10 2000-10-24 Abbott Laboratories Infant formula and methods of improving infant stool patterns
CA2180464C (en) * 1994-01-10 2001-08-14 Marc Leif Masor Enteral formula with ribo-nucleotides
JP3878690B2 (ja) * 1995-09-29 2007-02-07 森永乳業株式会社 乳幼児用乳糖含有食品組成物
JP2001516343A (ja) 1997-02-21 2001-09-25 アボツト・ラボラトリーズ 壊死性全腸炎の発生を減少させるための方法及び組成物
EP1034704A1 (en) * 1999-03-12 2000-09-13 Societe Des Produits Nestle S.A. Nutritional composition intended for specific gastro-intestinal maturation in premature mammals
US6365218B1 (en) * 2000-02-04 2002-04-02 Abbott Laboratories Pediatric formula and methods for providing nutrition and improving tolerance
US6207638B1 (en) * 2000-02-23 2001-03-27 Pacifichealth Laboratories, Inc. Nutritional intervention composition for enhancing and extending satiety
ATE369045T1 (de) 2001-11-26 2007-08-15 Nestec Sa Lagerstabiles nahrungsmittelprodukt enthaltend molkenprotein, verfahren zu seiner herstellung und verwendung
RU2262867C2 (ru) * 2002-02-14 2005-10-27 Катков Юрий Адольфович Бад к пище для улучшения репродукции человека (варианты)
TWI317636B (en) 2002-11-22 2009-12-01 Meiji Dairies Corp Nutritional compositions for liver disease patients or for patients underhigh levels of invasive stress
US7090879B2 (en) 2004-03-18 2006-08-15 Abbott Laboratories Nutritional formula containing select carotenoid combinations
WO2006069918A1 (en) 2004-12-27 2006-07-06 Nestec S.A. Use of infant formula with reduced protein content
US20070281054A1 (en) * 2006-05-31 2007-12-06 Abbott Laboratories Organic powder nutritional formula containing select carbohydrate combinations

Also Published As

Publication number Publication date
JP2011507517A (ja) 2011-03-10
US8361534B2 (en) 2013-01-29
AR069839A1 (es) 2010-02-24
IL206200A0 (en) 2010-12-30
MX2010006891A (es) 2010-10-15
CO6280446A2 (es) 2011-05-20
EP2227099A2 (en) 2010-09-15
CL2008003807A1 (es) 2009-10-16
DK2227099T3 (en) 2015-06-15
TW200934396A (en) 2009-08-16
AU2008343687A1 (en) 2009-07-09
HK1145275A1 (en) 2011-04-15
DOP2010000174A (es) 2010-06-30
ZA201004029B (en) 2011-04-28
WO2009085386A2 (en) 2009-07-09
RU2010129985A (ru) 2012-01-27
CR11509A (es) 2010-12-16
GT201000174A (es) 2012-04-03
US20090162521A1 (en) 2009-06-25
TWI418308B (zh) 2013-12-11
ECSP10010261A (es) 2010-07-30
MY150500A (en) 2014-01-30
RU2479219C2 (ru) 2013-04-20
EP2227099B1 (en) 2015-03-04
CA2708272C (en) 2015-10-13
ES2535144T3 (es) 2015-05-06
NZ585574A (en) 2012-06-29
CN101998835A (zh) 2011-03-30
CA2708272A1 (en) 2009-07-09
IL206200A (en) 2015-05-31
WO2009085386A3 (en) 2009-09-17
PA8808801A1 (es) 2009-07-23
PE20091454A1 (es) 2009-10-25

Similar Documents

Publication Publication Date Title
BRPI0820584A2 (pt) Pó nutricional estável
BRPI0823502A2 (pt) pó nutricional estável
NO2020043I1 (no) calcifediol
BRPI0914745A2 (pt) composição nutricional
HRP20150311T1 (xx) Instant napitak u prahu
BRPI0807453A2 (pt) Preparação sólida
BRPI1010709A2 (pt) composição nutricional
DK3354267T3 (da) Stabiliseret sulforaphan
BRPI0817910A2 (pt) Suplemento alimentício granular
EP2197299A4 (en) NÄHRZUSATZSTOFF
DK2178589T3 (da) Pulverinhalator
FR2935592B1 (fr) Poudrier
DK2125048T3 (da) Præparat
CR9612S (es) Contenedor
BRPI0914940A2 (pt) composições nutritivas contendo punicalaginas
FR2900034B1 (fr) Poudrier.
PT2309878T (pt) Purgantes dietéticos
FR2896135B1 (fr) Poudrier
DE602008002613D1 (de) Behälter
CR9618S (es) Contenedor
ATE506032T1 (de) Endoprothesenkomponente
EP2167674A4 (en) FOOD COMPOSITION
ITBO20070832A1 (it) Cotile
EP2086355A4 (en) NÄHRZUSATZSTOFF
DK2181229T3 (da) Scene

Legal Events

Date Code Title Description
B15I Others concerning applications: loss of priority
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]